β-Cell–Specific Protein Kinase A Activation Enhances the Efficiency of Glucose Control by Increasing Acute-Phase Insulin Secretion
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Acute insulin secretion determines the efficiency of glucose clearance. Moreover, impaired acute insulin release is characteristic of reduced glucose control in the prediabetic state. Incretin hormones, which increase β-cell cAMP, restore acute-phase insulin secretion and improve glucose control. To determine the physiological role of the cAMP-dependent protein kinase (PKA), a mouse model was developed to increase PKA activity specifically in the pancreatic β-cells. In response to sustained hyperglycemia, PKA activity potentiated both acute and sustained insulin release. In contrast, a glucose bolus enhanced acute-phase insulin secretion alone. Acute-phase insulin secretion was increased 3.5-fold, reducing circulating glucose to 58% of levels in controls. Exendin-4 increased acute-phase insulin release to a similar degree as PKA activation. However, incretins did not augment the effects of PKA on acute-phase insulin secretion, consistent with incretins acting primarily via PKA to potentiate acute-phase insulin secretion. Intracellular calcium signaling was unaffected by PKA activation, suggesting that the effects of PKA on acute-phase insulin secretion are mediated by the phosphorylation of proteins involved in β-cell exocytosis. Thus, β-cell PKA activity transduces the cAMP signal to dramatically increase acute-phase insulin secretion, thereby enhancing the efficiency of insulin to control circulating glucose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“GLP-1 also activates the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which is crucial for maintaining the survival and function of pancreatic β-cells.184–187”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [184]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132 · cited 1×
“The PKA inhibitors H89 and KT5720 inhibit a number of other kinases with similar or greater efficacy than PKA (37).”
BackgroundKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Low access resistance perforated patch recordings using amphotericin B
Rae, J., Cooper, K., Gates, P., & Watsky, M. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90017-t · Cited by 917 · cited 1×
“Patch electrodes were used as previously described (23) to record b-cells identified by a resting membrane”
MethodBagdade, J. D., Bierman, E. L., & Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105646 · Cited by 672
Dynamics of Insulin Secretion by the Perfused Rat Pancreas
CURRY, D. L., BENNETT, L. L., & GRODSKY, G. M. (1968) · Endocrinology · doi:10.1210/endo-83-3-572 · Cited by 601 · cited 1×
“Glucose-stimulated insulin release is biphasic, characterized by an initial acute burst of insulin secretion followed by a sustained suprabasal release of insulin (1,2).”
BackgroundAbnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.
Polonsky, K. S., Given, B. D., Hirsch, L. J., Tillil, H., Shapiro, E. T., Beebe, C., Frank, B. H., Galloway, J. A., & Van Cauter, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181903 · Cited by 567 · cited 1×
“Progression to type 2 diabetes is characterized by a loss in b-cell function, a critical feature of which is reduced acutephase insulin release (32,33).”
BackgroundPKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Seino, S., & Shibasaki, T. (2005) · Physiological Reviews · doi:10.1152/physrev.00001.2005 · Cited by 563 · cited 5×
“The EPAC-specific cAMP analog, 8-pCPT-29-O-MecAMP, also activates PKA, albeit with a 10-fold higher Kd than EPAC in cell free assays.”
BackgroundInfluentialBRUNZELL, J. D., ROBERTSON, R. P., LERNER, R. L., HAZZARD, W. R., ENSINCK, J. W., BIERMAN, E. L., & PORTE, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-222 · Cited by 505 · cited 1×
“Progression to type 2 diabetes is characterized by a loss in b-cell function, a critical feature of which is reduced acutephase insulin release (32,33).”
BackgroundThiebaud, D., Jacot, E., Defronzo, R. A., Maeder, E., Jequier, E., & Felber, J.-P. (1982) · Diabetes · doi:10.2337/diacare.31.11.957 · Cited by 489 · cited 2×
“This phase of insulin release, however, is absolutely critical in determining the efficiency of blood glucose clearance and does so by increasing the transendothelial transportation of insulin into skeletal muscle, where up to 80% of glucose uptake occurs (5).”
BackgroundEpac: Defining a New Mechanism for cAMP Action
Gloerich, M., & Bos, J. L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105714 · Cited by 473 · cited 1×
“In addition, 8-pCPT-29-O-MecAMP inhibits phosphodiesterases 1, 2, and 6, and so this can increase cAMP and cGMP levels (38,39).”
Background
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Regulation of Glucose Homeostasis by GLP-1
Nadkarni, P., Chepurny, O. G., & Holz, G. G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800101-1.00002-8 · Cited by 287
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
Yang, H., & Yang, L. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0316 · Cited by 203
Navarro, G., Xu, W., Jacobson, D. A., Wicksteed, B., Allard, C., Zhang, G., De Gendt, K., Kim, S. H., Wu, H., Zhang, H., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.015 · Cited by 171
“Consistent with AR signaling via a PKA pathway, transgenic mice with enhanced PKA catalytic activity in pancreatic islets (Kaihara et al., 2013; Song et al., 2011) exhibit increased GSIS but, like male bARKO /y mice, show no change in b cell mass or insulin synthesis.”
Self-citationSmith, E. P., An, Z., Wagner, C., Lewis, A. G., Cohen, E. B., Li, B., Mahbod, P., Sandoval, D., Perez-Tilve, D., Tamarina, N., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.005 · Cited by 164
“Transgenic Lines The MIPcreER line generation has been previously described (Kaihara et al., 2013; Wicksteed et al., 2010) with more characterization in the Supplemental Information (see also Figure S2 and Figure S2 legend).”
MethodSelf-citationHuman β-Cell Proliferation and Intracellular Signaling: Part 3
Stewart, A. F., Hussain, M. A., García-Ocaña, A., Vasavada, R. C., Bhushan, A., Bernal-Mizrachi, E., & Kulkarni, R. N. (2015) · Diabetes · doi:10.2337/db14-1843 · Cited by 142
“Surprisingly, in vivo b-cell–selective upregulation of PKA signaling in mice markedly potentiates glucose-stimulated insulin secretion (GSIS) but does not stimulate b-cell proliferation (71,72).”
BackgroundThe therapeutic potential of GLP‐1 receptor biased agonism
Jones, B. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15497 · Cited by 107
“…of evidence, including by observing the effects of pharmacological PKA inhibition (Skoglund et al., 2000), genetic manipulation of PKA activity (Kaihara et al., 2013) and inter- ference with the correct localisation of PKA by disrupting A-kinase anchoring proteins (AKAPs) (Lester et al.,…”
BackgroundNovikoff, A., O'Brien, S. L., Bernecker, M., Grandl, G., Kleinert, M., Knerr, P. J., Stemmer, K., Klingenspor, M., Zeigerer, A., DiMarchi, R., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101181 · Cited by 95
Activation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84
Oropeza, D., Jouvet, N., Budry, L., Campbell, J. E., Bouyakdan, K., Lacombe, J., Perron, G., Bergeron, V., Neuman, J. C., Brar, H. K., et al. (2015) · Diabetes · doi:10.2337/db15-0272 · Cited by 86
“Interestingly, we did not observe impairment in glucose tolerance or GSIS, as was reported for Pdx1-Cre Late mice (3), supporting previous studies using MIP-CreERT mice on various genetic backgrounds (16; 33-35).”
Wu, B., Wei, S., Petersen, N., Ali, Y., Wang, X., Bacaj, T., Rorsman, P., Hong, W., Südhof, T. C., & Han, W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513004112 · Cited by 76
“Mouse models with constitutively increased PKA activity have established PKA’s predominant role in the GLP-1–induced potentiation of β-cell GSIS (7, 8), but the downstream effectors remain unidentified.”
BackgroundFeedback Inhibition of CREB Signaling Promotes Beta Cell Dysfunction in Insulin Resistance
Blanchet, E., Van de Velde, S., Matsumura, S., Hao, E., LeLay, J., Kaestner, K., & Montminy, M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.046 · Cited by 73
“, 2011) or via a gain-of-function mutation in the PKA catalytic subunit (Kaihara et al., 2013), enhances insulin secretion.”
Backgroundβ-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1
Suriben, R., Kaihara, K. A., Paolino, M., Reichelt, M., Kummerfeld, S., Modrusan, Z. D., Dugger, D. L., Newton, K., Sagolla, M. S., Webster, J. D., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.076 · Cited by 85
“Calcium Imaging As previously described (Kaihara et al., 2013), isolated islets were incubated with 5 mM fura-2-AM (Invitrogen) in 2 mM glucose-Kreb’s buffer for 30 min.”
InfluentialSelf-citationGlucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion
Fine, N. H. F., Doig, C. L., Elhassan, Y. S., Vierra, N. C., Marchetti, P., Bugliani, M., Nano, R., Piemonti, L., Rutter, G. A., Jacobson, D. A., et al. (2018) · Diabetes · doi:10.2337/db16-1356 · Cited by 61
“granule pool through Epac2 and PKA (40,41), and this may account for the intact secretory responses to glucose and KCl.”
BackgroundSelf-citationXia, T., He, W., Luo, Z., Wang, K., & Tan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132256 · Cited by 64
Dickson, L. M., Gandhi, S., Layden, B. T., Cohen, R., & Wicksteed, B. L. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00114.2016 · Cited by 51
Self-citationTrevino, M. B., Machida, Y., Hallinger, D. R., Garcia, E., Christensen, A., Dutta, S. M., Peake, D. A., Ikeda, Y., & Imai, Y. (2014) · Diabetes · doi:10.2337/db14-0559 · Cited by 51
“Likewise, detailed analyses of the insulin secretory pathways through which PLIN5 collaborates with FA and cAMP to augment insulin secretion are warranted, considering FA and cAMP both upregulate GSIS at multiple steps, including exocytosis machineries distal to the rise in [Ca]i (8,35,48).”
BackgroundAntidiabetic Sulfonylureas and cAMP Cooperatively Activate Epac2A
Takahashi, T., Shibasaki, T., Takahashi, H., Sugawara, K., Ono, A., Inoue, N., Furuya, T., & Seino, S. (2013) · Science Signaling · doi:10.1126/scisignal.2004581 · Cited by 49
Cooperation between cAMP signalling and sulfonylurea in insulin secretion
Shibasaki, T., Takahashi, T., Takahashi, H., & Seino, S. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12343 · Cited by 49
“In β-cells, both type I and type II PKA holoenzymes are expressed [40].”
BackgroundYang, K., & Chan, C. B. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.174 · Cited by 45
Henquin, J.-C., & Nenquin, M. (2014) · Endocrinology · doi:10.1210/en.2014-1247 · Cited by 41
Fighting Diabetes Mellitus: Pharmacological and Non-pharmacological Approaches
Wang, X., Kang, J., Liu, Q., Tong, T., & Quan, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200728144200 · Cited by 45
Multilevel control of glucose homeostasis by adenylyl cyclase 8
Raoux, M., Vacher, P., Papin, J., Picard, A., Kostrzewa, E., Devin, A., Gaitan, J., Limon, I., Kas, M. J., Magnan, C., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3445-z · Cited by 41
Gong, B., Li, C., Shi, Z., Wang, F., Dai, R., Chen, G., & Su, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675552 · Cited by 36
Kahancová, A., Sklenář, F., Ježek, P., & Dlasková, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58411-x · Cited by 34
Ao, R., Wang, Y., Tong, J., & Wang, B. (2016) · Medical Science Monitor · doi:10.12659/msm.897207 · Cited by 31
Repurposing cAMP-Modulating Medications to Promote β-Cell Replication
Zhao, Z., Low, Y., Armstrong, N., Kenty, J. H.-R., Sun, S. A., Arvanites, A. C., Hollister‐Lock, J., Shah, N. H., Weir, G. C., & Annes, J. P. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1120 · Cited by 30
Swimming regulations for protein kinase a catalytic subunit
Gold, M. G. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190230 · Cited by 30
Exendin-4 protects rat islets against loss of viability and function induced by brain death
Carlessi, R., Lemos, N. E., Dias, A. L., de Oliveira, F. S., Brondani, L. D. A., Canani, L. H. S., Bauer, A. C., Leitão, C. B., & Crispim, D. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.009 · Cited by 29
“Regarding the metabolic actions of GLP1 analogs on β-cells, PKA activation and subsequent phosphorylation of its downstream targets is the primary pathway for potentiation of glucose-dependent insulin secretion (Kaihara et al., 2013).”
Local cyclic adenosine monophosphate signalling cascades—Roles and targets in chronic kidney disease
Sholokh, A., & Klußmann, E. (2021) · Acta Physiologica · doi:10.1111/apha.13641 · Cited by 28
Molecular regulation of insulin granule biogenesis and exocytosis
Röder, P. V., Wong, X. M., Hong, W., & Han, W. (2016) · Biochemical Journal · doi:10.1042/bcj20160291 · Cited by 30
Veluthakal, R., Chepurny, O. G., Leech, C. A., Schwede, F., Holz, G. G., & Thurmond, D. C. (2018) · Diabetes · doi:10.2337/db17-1174 · Cited by 26
RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome
Meyer, R. K., & Duca, F. A. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0019 · Cited by 28
Barać, M., & Roganović, J. (2025) · Biology · doi:10.3390/biology14121650 · Cited by 32
“Beyond cAMP-mediated mechanisms, GLP-1 signaling also engages the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which is critical for preserving the survival, proliferation, and function of pancreatic β -cells [23–26].”
PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control
Kaihara, K. A., Dickson, L. M., Ellenbroek, J. H., Orr, C. M. D., Layden, B. T., & Wicksteed, B. (2015) · Diabetes · doi:10.2337/db14-1051 · Cited by 22
“β-caPKA mice have β-cell specific, Cre-inducible increased PKA activity upon tamoxifen administration (16).”
InfluentialSelf-citationIncretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact
Lee, A. A., Khotina, V. A., Kashirskikh, D. A., Voronko, O. E., Gasanov, V. A. O., & Vasiliev, A. V. (2025) · Medical Sciences · doi:10.3390/medsci13040269 · Cited by 26
Cochrane, V., Yang, Z.-Y., Dell'Acqua, M., & Shyng, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100442 · Cited by 15
GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo
Arcones, A. C., Vila‐Bedmar, R., Mirasierra, M., Cruces‐Sande, M., Vallejo, M., Jones, B. J., Tomás, A., Mayor, F., & Murga, C. (2021) · BMC Biology · doi:10.1186/s12915-021-00966-w · Cited by 18
“Total insulin content of the pancreas was analyzed by acidic extraction of insulin protein as described [20].”
BackgroundMethodA practical guide to genetic engineering of pancreatic β-cellsin vivo: Getting a grip on RIP and MIP
Johnson, J. D. (2014) · Islets · doi:10.4161/19382014.2014.944439 · Cited by 17
“demonstrates for the first time that a target gene, in this case b-catenin, can be robustly down-regulated using the MIP1-CreERT deleter mouse line,(35) although MIP-Cre has previously been used to activate a target gene in b-cells.(43) It is expected that there will be some caveats with this model, as there always ar…”
MethodBBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice
Yao, X., Xu, X., Wang, G., Lei, M., Quan, L.-L., Cheng, Y., Wan, P., Zhou, J.-P., Chen, J., Hu, L., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0721 · Cited by 16
“Elevation of intracellular cAMP directly activates cAMPdependent PKA, thereby potentiating GSIS (Kaihara et al. 2013).”
BackgroundAli, A., Khan, D., Dubey, V., Tarasov, A. I., Flatt, P. R., & Irwin, N. (2024) · Biomolecules · doi:10.3390/biom14121520 · Cited by 15
Freeze‐Dried Mesenchymal Stem Cells: From Bench to Bedside. Review
Paresishvili, T., & Kakabadze, Z. (2023) · Advanced Biology · doi:10.1002/adbi.202300155 · Cited by 15
Increasing β-Cell Mass Requires Additional Stimulation for Adaptation to Secretory Demand
Mondal, P., Song, W., Li, Y., Yang, K. S., & Hussain, M. A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1265 · Cited by 14
Lippo, B. R. D. S., Batista, T. M., de Rezende, L. F., Cappelli, A. P. G., Camargo, R. L., Branco, R. C. S., Barbosa, H. C. L., Protzek, A. O. P., Wanderley, M. I., Arantes, V. C., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.12.010 · Cited by 13
A PDX1 cistrome and single-cell transcriptome resource of the developing pancreas
Yang, X., Raum, J. C., Kim, J., Yu, R., Yang, J., Rice, G., Li, C., Won, K., Stoffers, D. A., & Stanescu, D. E. (2022) · Development · doi:10.1242/dev.200432 · Cited by 13
He, S., Wu, W., Wan, Y., Nandakumar, K. S., Cai, X., Tang, X., Liu, S., & Yao, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01230 · Cited by 13
“Interestingly, the acute phase of insulin secretion was increased and blood glucose was effective control in PKA Cα subunit knock in mice (Kaihara et al., 2013), so PKA Cα was overexpressed or knocked out throughout this study.”
BackgroundNoncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 13
Molecular Basis of cAMP Signaling in Pancreatic β Cells
Holz, G. G., Chepurny, O. G., Leech, C. A., Song, W., & Hussain, M. A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_25 · Cited by 12
“These findings obtained with Δprkar1a mice are similar to findings obtained using mice that are engineered to allow inducible expression of a constitutively active PKAcs transgene specifically in β-cells (Kaihara et al. 2013).”
BackgroundInfluentialVadlakonda, L., Indracanti, M., Kalangi, S. K., Gayatri, B. M., Gajula, N. N., & Reddy, A. B. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00566-5 · Cited by 11
Gerber, K. M., Whitticar, N. B., Rochester, D. R., Corbin, K. L., Koch, W. J., & Nunemaker, C. S. (2021) · Metabolites · doi:10.3390/metabo11060401 · Cited by 12
“This paradoxical stimulation of glucagon release occurs around at least 25–30 mM [30,31].”
BackgroundBisht, S., & Singh, M. F. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2299920 · Cited by 11
“Phosphorylation can activate motor proteins and cytoskeletal elements, facilitating the movement of insulin granules exo-cytosis (Henquin 2000, Kaihara et al .”
Beta cells intrinsically sense and limit their secretory activity via mTORC1-RhoA signaling
Krell, S., Hamburg, A., Gover, O., Molakandov, K., Leibowitz, G., Sharabi, K., WALKER, M. D., & Helman, A. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115647 · Cited by 9
Ni, Z., Wang, Y., Shi, C., Zhang, X., Gong, H., & Dong, Y. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04089-y · Cited by 11
“Further, cAMP can also regulate the secretion of incretin by activating PKA, while blocking its pathway in β cells leads to severe glucose intolerance and β cell apoptosis [40, 41].”
BackgroundLee, H. N., Hardy, J. C., Pool, E. H., Zhang, J., Kim, S. H., Buhl, W. F., Bruystens, J. G. H., Mehta, S., Taylor, S. S., & Zhang, J. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003262 · Cited by 8
Torchio, S., Siracusano, G., Cuozzo, F., Zamarian, V., Pellegrini, S., Manenti, F., Bonfanti, R., Frontino, G., Sordi, V., Chimienti, R., et al. (2025) · Diabetes · doi:10.2337/db24-0720 · Cited by 8
Jiang, Y., Zhu, L., Wu, D., Ni, Y., Huang, C., Ye, H., Yang, Y., Liu, R., & Li, Y. (2021) · FEBS Journal · doi:10.1111/febs.16302 · Cited by 8
Lee, C., Chu, C., Tsai, H.-J., Ke, L., Lee, H., Yeh, J., Chen, C., & Wu, B. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.11.017 · Cited by 8
Villalpando, S., Cazevieille, C., Fernandez, A., Lamb, N. J. C., & Hani, E.-H. (2016) · Biochimie · doi:10.1016/j.biochi.2016.02.008 · Cited by 9
Interventions to improve β-cell mass and function
Mondal, P., Prasad, A., & Girdhar, K. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.11.002 · Cited by 8
Rahman, M. M., Pathak, A., Schueler, K. L., Alsharif, H. A., Michl, A. N., Alexander, J., Kim, J., & Bhatnagar, S. (2023) · The FASEB Journal · doi:10.1096/fj.202300291rr · Cited by 5
Almohammad, A. A., Aldossari, S. K., Sukumbaji, Z. A., Faden, R. A., Almutairi, M. A., Al-Harbi, N. H., Al-Saaib, M. Y., Almarshedy, B., Alharabi, E., Alhazri, W. A., et al. (2025) · Cureus · doi:10.7759/cureus.95792 · Cited by 9
“Together, the cAMP-PKA/EPAC and PI3K/Akt branches provide acute insulinotropic effects alongside trophic support for β -cell health [37-41].”
InfluentialIdentifying target ion channel-related genes to construct a diagnosis model for insulinoma
Mo, S., Wang, Y., Wu, W.-H., Zhao, H., Jiang, H., & Qin, S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1181307 · Cited by 5
“, 2012), and incretin hormones increase the cAMP of β-cells (Kaihara et al., 2013).”
Wang, X., Lu, G., Zhou, Y., & Zhao, G. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02891-7 · Cited by 4
Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study
Chuang, C.-H., Tsai, P., Kao, S.-W., Wang, Y., & Yeh, C. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2025.072875 · Cited by 3
“In addition, GLP-1 signaling engages the PI3K/AKT pathway, which is essential for β-cell survival and function, and can also activate MAPK/ERK cascades involved in cell growth and proliferation [3,4].”
Pancreatic δ Cells: An Overlooked Cell in Focus
Golson, M. L. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_6 · Cited by 3
Levine, J. A., Kaihara, K. A., Layden, B. T., & Wicksteed, B. L. (2016) · Islets · doi:10.1080/19382014.2016.1198457 · Cited by 3
Self-citationPeptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials
Barzgar, H., Darmadi, D., Nafisa, J., Narkulov, S., & Sviridova, M. B. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120772 · Cited by 2
GLP-1 and Parkinson’s Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy
Mezabrovschi, R., Gegg, M. E., & Schapira, A. H. V. (2026) · Cells · doi:10.3390/cells15090804 · Cited by 3
Achieving “PeaK-A” Insulin Secretion
Evans‐Molina, C., & Mirmira, R. G. (2013) · Diabetes · doi:10.2337/db13-0196 · Cited by 2
Diabetes-associated Genetic Variation in MTNR1B and Its Effect on Islet Function
Vella, M., Mohan, S., Christie, H. E., Bailey, K. R., Cobelli, C., Man, C. D., Matveyenko, A. V., Egan, A. M., & Vella, A. V. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae130 · Cited by 1
“Indeed, activation of protein kinase A is essential for glucose-stimulated insulin secretion [38].”
BackgroundRaj, N., Karmakar, A., Narayan, G., & Thummer, R. P. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_859 · Cited by 1
Liu, Y., Ni, Y., Xie, C., Fan, L., Jiang, Y., Sun, Q., Mao, B., Huang, C., Zhang, Z., Yang, Y., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06781-8 · Cited by 1
“The effects of PKA on first-phase insulin release lie downstream of Ca 2+ signalling and plasma membrane depo-larisation, as evidenced by overexpression of PKA catalytic subunit in pancreatic beta cells [34].”
Molecular Basis of cAMP Signaling in Pancreatic Beta Cells
Holz, G. G., Chepurny, O. G., Leech, C. A., Song, W., & Hussain, M. A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_25-3 · Cited by 1
Interplay of PAK1 and CAMKII in Pancreatic Beta Cell Insulin Secretion
López-Desiderio, N. G., Patiño‐López, G., Salinas‐Lara, C., Sánchez-Garibay, C., Cruz, O. V., Vilches‐Flores, A., Peralta‐Romero, J., Armas‐López, L., García‐Machorro, J., Arias‐Romero, L. E., et al. (2025) · Diabetology · doi:10.3390/diabetology6050039 · Cited by 1
“Previous studies have explored the potential of kinase activators in enhancing insulin secretion, with promising results in preclinical models [38,39].”
The activation of the glucagon-like peptide-1 (GLP-1) receptor by peptide and non-peptide ligands
Wishart, C. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Trinh, I. (2017) · TSpace (University of Toronto)
Hendijani, F., & Hosseini, F. S. (2022) · Personalized Medicine · doi:10.2217/pme-2021-0107
Rahman, M. M., Pathak, A., Schueler, K. L., Alsharif, H. A., Michl, A. N., Alexander, J., Kim, J.-A., Chapman, E. R., & Bhatnagar, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.20.513128
Additional file 1 of GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo
Arcones, A. C., Vila‐Bedmar, R., Mirasierra, M., Cruces‐Sande, M., Vallejo, M., Jones, B. J., Tomás, A., Mayor, F., & Murga, C. (2021) · Figshare · doi:10.6084/m9.figshare.14157718
Multicellular regulation of the pancreatic islet in diabetes
Fine, N. H. F. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham)
Impact of ZnT8 Deficiency on Insulin Synthesis and Secretion in a Beta-Cell Specific Knockout Model
Piro, A. (2023) · TSpace (University of Toronto)
Beig, J., Ta, J., Jones, S., Scott, E., Sofi, K., Osler, F., Jansen, M., & Chhabra, P. (2026) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.70059 · Cited by 1
“AT‐ mediated pathways) [34].”
Metadata
- Authors
- Kaihara, K. A., Dickson, L. M., Jacobson, D. A., Tamarina, N., Roe, M. W., Philipson, L. H., & Wicksteed, B.
- Affiliations
- University of Chicago (US)
- Vanderbilt University (US)
- SUNY Upstate Medical University (US)
- Corresponding author
- Wicksteed, Barton
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-04-16
- Volume
- 62
- Issue
- 5
- Pages
- 1527-1536
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3636652
- OpenAlex
- W2143340315
- Cited by
- 80
- References
- 51
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 12 · 2013: 3
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association (1-08-JF-58)
- McKnight Foundation
- University of Washington
- National Institutes of Health (5t32dk087703-05, DK020595, DK063493)
- Diabetes Research and Training Center (DK020595)
- National Institute on Aging (F31AG035620)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK087703, DK-063493, R01DK048494, DK074966, R01DK085129, R01DK063493, T32-DK-087703, DK020595, DK-085129, DK-48494, R01DK092616, R01DK074966, P60DK020595, P30DK020595)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cAMP signaling, sustained insulin release, glycemic control, prediabetes, incretins, exendin-4, hyperglycemia, pancreatic beta cells, glucose clearance
- MeSH terms
- Exenatide, Insulin Secretion, Cyclic AMP, Animals, Crosses, Genetic, Enzyme Induction, Hyperglycemia, Hypoglycemic Agents, Insulin, Kinetics, Peptides, Phosphorylation, Protein Processing, Post-Translational, Venoms, Second Messenger Systems, Glucose Clamp Technique, Up-Regulation, Cyclic AMP-Dependent Protein Kinases, Patch-Clamp Techniques, Protein Subunits, Insulin-Secreting Cells, Mutant Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.